Chairman’s introductionPeter Barth · 1996

Chairman’s introductionAnthony Campagnoni · 1996

Chairman’s introductionBryan Ross · 1996

Chairman’s introductionDavid Wenger · 1996

Chairman’s introductionHugo Moser · 1996

Chairman’s IntroductionK. Pavelka · 2002

Chairman’s introductionJean-Pierre Armand · 2006

Chairman’s IntroductionJ. D. Ward · Drugs · 1986

Prednisolone treatment of hereditary pig lymphomaSerena A. Brownlil; J.G. Campbell; K.W. Head; P. Imlah; H.S. McTaggart; J.G. McVie · 1965

The effects of prednisolone on normal pigsSerena E. Brownlie; J.G. Campbell; K.W. Head; P. Imlah; H.S. McTaggart; J.G. McVie · 1965

Monocyte function in cancer patientsJ.G. McVie; E.G.M. Logan; A.B. Kay · 1965

309 Why is cancer outcome different?J.G. McVie · 1995

Why clinical trials?J.G. McVie · 1995

Chairman's summaryJ.G. McVie · 1997

The clinical pharmacology of methotrexateSchornagel, J.H.; McVie, J.G. · Cancer Treatment Reviews · 1983